Spinocerebellar ataxia (SCA) is a debilitating group of neurodegenerative disorders that progressively affect movement and coordination. Formerly, treatment options have been limited to managing symptoms and improving quality of life. However, recent breakthroughs in research are offering new promise for patients with SCA. One promising avenue is

Multiple System Atrophy (MSA) presents a complex challenge for individuals and their support systems. While there is currently no cure for MSA, a variety of treatment options and management strategies can help to alleviate symptoms and improve quality of life. Medical interventions often focus on addressing the specific symptoms of MSA, such as au